IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 134 filers reported holding IMMUNOGEN INC in Q4 2013. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,443,742 | -37.7% | 90,973 | -62.8% | 0.01% | -20.0% |
| Q3 2018 | $2,319,000 | +6.5% | 244,847 | +9.4% | 0.02% | 0.0% |
| Q2 2018 | $2,178,000 | +0.7% | 223,740 | +8.8% | 0.02% | +200.0% |
| Q1 2018 | $2,163,000 | +25.5% | 205,722 | -23.5% | 0.01% | +25.0% |
| Q4 2017 | $1,724,000 | -10.9% | 268,889 | +18.4% | 0.00% | -33.3% |
| Q1 2016 | $1,935,000 | -20.4% | 227,055 | +26.8% | 0.01% | -14.3% |
| Q4 2015 | $2,431,000 | +114.9% | 179,114 | +52.1% | 0.01% | +133.3% |
| Q3 2015 | $1,131,000 | -38.4% | 117,783 | -60.9% | 0.00% | -40.0% |
| Q4 2014 | $1,836,000 | -29.3% | 301,045 | +22.8% | 0.01% | -16.7% |
| Q3 2014 | $2,596,000 | -0.1% | 245,170 | +11.8% | 0.01% | -14.3% |
| Q2 2014 | $2,598,000 | -30.3% | 219,218 | -12.1% | 0.01% | -36.4% |
| Q1 2014 | $3,726,000 | +15.9% | 249,520 | +13.9% | 0.01% | +10.0% |
| Q4 2013 | $3,215,000 | -19.1% | 219,150 | -6.2% | 0.01% | -28.6% |
| Q3 2013 | $3,976,000 | +29.8% | 233,641 | +26.5% | 0.01% | +7.7% |
| Q2 2013 | $3,064,000 | – | 184,670 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |